These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36208211)

  • 1. Strategies for Using Antigen Rapid Diagnostic Tests to Reduce Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Low- and Middle-Income Countries: A Mathematical Modelling Study Applied to Zambia.
    Han AX; Girdwood SJ; Khan S; Sacks JA; Toporowski A; Huq N; Hannay E; Russell CA; Nichols BE
    Clin Infect Dis; 2023 Feb; 76(4):620-630. PubMed ID: 36208211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of COVID rapid diagnostic tests for patients with severe/critical illness in low- and middle-income countries: A modeling study.
    Bonnet G; Bimba J; Chavula C; Chifamba HN; Divala TH; Lescano AG; Majam M; Mbo D; Suwantika AA; Tovar MA; Yadav P; Ekwunife O; Mangenah C; Ngwira LG; Corbett EL; Jit M; Vassall A
    PLoS Med; 2024 Jul; 21(7):e1004429. PubMed ID: 39024370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study.
    Grassly NC; Pons-Salort M; Parker EPK; White PJ; Ferguson NM;
    Lancet Infect Dis; 2020 Dec; 20(12):1381-1389. PubMed ID: 32822577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom-based vs asymptomatic testing for controlling SARS-CoV-2 transmission in low- and middle-income countries: A modelling analysis.
    Baik Y; Cilloni L; Kendall E; Dowdy D; Arinaminpathy N
    Epidemics; 2022 Dec; 41():100631. PubMed ID: 36174427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing required SARS-CoV-2 blanket testing rates for possible control of the outbreak in the epicentre Lusaka province of Zambia with consideration for asymptomatic individuals: A simple mathematical modelling study.
    Sichone J; Sinkala M; Munsaka S; Kikonko M; Simuunza M
    PLoS One; 2021; 16(4):e0249479. PubMed ID: 33822785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional Evaluation of Two SARS-CoV-2 Antigen Rapid Diagnostic Tests in East Africa.
    Affara M; Lagu HI; Achol E; Omari N; Ochido G; Kezakarayagwa E; Kabatesi F; Nduwimana C; Nkeshimana A; Duku Samson D; Awin Nykwec G; Daniel Wani Lako J; Lasuba M; Lojok Deng L; Ezekiely Kelly M; Bernard Mtesigwa Mkama P; Magesa A; Said Ali S; Amour Rashid S; Pimundu G; Muyigi T; Ndidde Nabadda S; Rutayisire R; Kabanda A; Kabalisa E; May J; Nzeyimana E; Katende M; Gehre F
    Microbiol Spectr; 2023 Jun; 11(3):e0489522. PubMed ID: 37010436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Test negative case-control study of COVID-19 vaccine effectiveness for symptomatic SARS-CoV-2 infection among healthcare workers: Zambia, 2021-2022.
    Mweso O; Simwanza J; Malambo W; Banda D; Fwoloshi S; Sinyange N; Yoo YM; Feldstein LR; Kapina M; Mulenga LB; Liwewe MM; Musonda K; Kapata N; Mwansa FD; Agolory S; Bobo P; Hines J; Chilengi R
    BMJ Open; 2023 Dec; 13(12):e072144. PubMed ID: 38072491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing in low-middle income countries and possible cost-effective measures in resource-limited settings.
    Duma Z; Chuturgoon AA; Ramsuran V; Edward V; Naidoo P; Mpaka-Mbatha MN; Bhengu KN; Nembe N; Pillay R; Singh R; Mkhize-Kwitshana ZL
    Global Health; 2022 Jan; 18(1):5. PubMed ID: 35065670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021.
    Cohen C; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; du Plessis M; Carrim M; Buys A; Martinson NA; Kahn K; Tollman S; Lebina L; Wafawanaka F; du Toit J; Xavier Gómez-Olivé F; Dawood FS; Mkhencele T; Sun K; Viboud C; ; Tempia S
    medRxiv; 2021 Dec; ():. PubMed ID: 34909794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing for SARS-CoV-2 in resource-limited settings: A cost analysis study of diagnostic tests using different Ag-RDTs and RT-PCR technologies in Mozambique.
    Manjate NJ; Sitoe N; Sambo J; Guimarães E; Canana N; Chilaúle J; Viegas S; Nguenha N; Jani I; Russo G
    PLOS Glob Public Health; 2023; 3(6):e0001999. PubMed ID: 37310935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avoiding False-Positive SARS-CoV-2 Rapid Antigen Test Results with Point-of-Care Molecular Testing on Residual Test Buffer.
    LeBlanc JJ; McCracken GR; Goodall B; Hatchette TF; Barrett L; Ross J; Davidson RJ; Patriquin G
    Microbiol Spectr; 2022 Aug; 10(4):e0063922. PubMed ID: 35863036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Mar; 25(21):1-68. PubMed ID: 33764295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creating access to SARS-CoV-2 screening and testing through community-based COVID-19 case-finding, observations from cross-sectional studies in Lesotho and Zambia.
    Klinkenberg E; Katende B; Ruperez M; Bresser M; Kangololo B; Bwalya J; Erhardt RM; Schaap A; Kasese N; Gatchie T; Floyd S; 'Mota 'J; Ayles H; Shanaube K; Reither K
    BMC Public Health; 2023 Jul; 23(1):1414. PubMed ID: 37488552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study.
    Eyre DW; Futschik M; Tunkel S; Wei J; Cole-Hamilton J; Saquib R; Germanacos N; Dodgson AR; Klapper PE; Sudhanva M; Kenny C; Marks P; Blandford E; Hopkins S; Peto TEA; Fowler T
    Lancet Infect Dis; 2023 Aug; 23(8):922-932. PubMed ID: 37001541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Rapid Antigen Tests to Detect Symptomatic and Asymptomatic SARS-CoV-2 Infection : A Prospective Cohort Study.
    Soni A; Herbert C; Lin H; Yan Y; Pretz C; Stamegna P; Wang B; Orwig T; Wright C; Tarrant S; Behar S; Suvarna T; Schrader S; Harman E; Nowak C; Kheterpal V; Rao LV; Cashman L; Orvek E; Ayturk D; Gibson L; Zai A; Wong S; Lazar P; Wang Z; Filippaios A; Barton B; Achenbach CJ; Murphy RL; Robinson ML; Manabe YC; Pandey S; Colubri A; O'Connor L; Lemon SC; Fahey N; Luzuriaga KL; Hafer N; Roth K; Lowe T; Stenzel T; Heetderks W; Broach J; McManus DD
    Ann Intern Med; 2023 Jul; 176(7):975-982. PubMed ID: 37399548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Rapid Antigen Tests' Performance Between Delta and Omicron Variants of SARS-CoV-2 : A Secondary Analysis From a Serial Home Self-testing Study.
    Soni A; Herbert C; Filippaios A; Broach J; Colubri A; Fahey N; Woods K; Nanavati J; Wright C; Orwig T; Gilliam K; Kheterpal V; Suvarna T; Nowak C; Schrader S; Lin H; O'Connor L; Pretz C; Ayturk D; Orvek E; Flahive J; Lazar P; Shi Q; Achenbach C; Murphy R; Robinson M; Gibson L; Stamegna P; Hafer N; Luzuriaga K; Barton B; Heetderks W; Manabe YC; McManus D
    Ann Intern Med; 2022 Dec; 175(12):1685-1692. PubMed ID: 36215709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.